J Knee Surg 2020; 33(08): 838-846
DOI: 10.1055/s-0040-1701452
Original Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Medial Meniscus Scaffold Implantation in Combination with Concentrated Bone Marrow Aspirate Injection: Minimum 3-Year Follow-up

Mustafa Akkaya
1   Department of Orthopedics and Traumatology, Faculty of Medicine, Ankara Yildirim Beyazit University, Ankara, Turkey
,
Mehmet Emin Şimşek
2   Department of Orthopedics and Traumatology, Faculty of Medicine, Lokman Hekim University, Ankara, Turkey
,
Safa Gürsoy
1   Department of Orthopedics and Traumatology, Faculty of Medicine, Ankara Yildirim Beyazit University, Ankara, Turkey
,
Nurdan Çay
3   Department of Radiology, Faculty of Medicine, Ankara Yildirim Beyazit University, Ankara, Turkey
,
Murat Bozkurt
1   Department of Orthopedics and Traumatology, Faculty of Medicine, Ankara Yildirim Beyazit University, Ankara, Turkey
› Author Affiliations
Further Information

Publication History

15 June 2019

13 December 2019

Publication Date:
10 February 2020 (online)

Abstract

The objective of this study is to show the short-term clinical and radiological outcomes of concentrated bone marrow aspirate (CBMA) injection administered in combination with medial meniscus scaffold implantation. Twenty-three patients who received intra-articular CBMA injection in combination with polyurethane-based medial meniscus scaffold implantation were evaluated within the scope of this study. The International Knee Documentation Committee (IKDC) questionnaire and the Knee injury and Osteoarthritis Outcome Score (KOOS) were used to evaluate the results, and the visual analog scale was used to assess the pain scores. Magnetic resonance imaging (MRI) scans were obtained in the preoperative period and at postoperative months 1, 12, 24, and 36 to assess the scaffold position as well as chondral degeneration/damage in a comparative manner. MRI assessment was performed by using the modified Outerbridge scale for cartilage and the Genovese scoring system for the meniscal implant. Twenty-three patients who were included in the study were evaluated for a mean follow-up period of 38.3 months. Patients exhibited statistically significant improvement according to all scoring data from the preoperative period until the follow-up period. The mean postoperative extrusion at year 3 was 2.39 mm (distribution 2.30–2.56 mm). There was no significant difference in the distribution of the degree of chondral damage between the preoperative and 3-year follow-up periods. Four patients did not show any improvement nor had lower scores according to the assessment. Medial meniscus scaffold implantation combined with intra-articular CBMA injection resulted in a significant improvement in all functions and pain scores as well as a statistically significant clinical improvement in IKDC and KOOS values in the short-term follow-up. The Level of evidence for this study is IV.

 
  • References

  • 1 Verdonk P, Beaufils P, Bellemans J. , et al; Actifit Study Group. Successful treatment of painful irreparable partial meniscal defects with a polyurethane scaffold: two-year safety and clinical outcomes. Am J Sports Med 2012; 40 (04) 844-853
  • 2 Feeley BT, Lau BC. Biomechanics and clinical outcomes of partial meniscectomy. J Am Acad Orthop Surg 2018; 26 (24) 853-863
  • 3 Englund M, Roos EM, Roos HP, Lohmander LS. Patient-relevant outcomes fourteen years after meniscectomy: influence of type of meniscal tear and size of resection. Rheumatology (Oxford) 2001; 40 (06) 631-639
  • 4 Packer JD, Rodeo SA. Meniscal allograft transplantation. Clin Sports Med 2009; 28 (02) 259-283 , viii
  • 5 De Bruycker M, Verdonk PCM, Verdonk RC. Meniscal allograft transplantation: a meta-analysis. SICOT J 2017; 3: 33
  • 6 Elattar M, Dhollander A, Verdonk R, Almqvist KF, Verdonk P. Twenty-six years of meniscal allograft transplantation: is it still experimental? A meta-analysis of 44 trials. Knee Surg Sports Traumatol Arthrosc 2011; 19 (02) 147-157
  • 7 Zaffagnini S, Marcheggiani Muccioli GM, Lopomo N. , et al. Prospective long-term outcomes of the medial collagen meniscus implant versus partial medial meniscectomy: a minimum 10-year follow-up study. Am J Sports Med 2011; 39 (05) 977-985
  • 8 Efe T, Getgood A, Schofer MD. , et al. The safety and short-term efficacy of a novel polyurethane meniscal scaffold for the treatment of segmental medial meniscus deficiency. Knee Surg Sports Traumatol Arthrosc 2012; 20 (09) 1822-1830
  • 9 Drobnič M, Ercin E, Gamelas J. , et al. Treatment options for the symptomatic post-meniscectomy knee. Knee Surg Sports Traumatol Arthrosc 2019; 27 (06) 1817-1824
  • 10 Dhollander A, Verdonk P, Verdonk R. Treatment of painful, irreparable partial meniscal defects with a polyurethane scaffold: midterm clinical outcomes and survival analysis. Am J Sports Med 2016; 44 (10) 2615-2621
  • 11 Leroy A, Beaufils P, Faivre B, Steltzlen C, Boisrenoult P, Pujol N. Actifit® polyurethane meniscal scaffold: MRI and functional outcomes after a minimum follow-up of 5 years. Orthop Traumatol Surg Res 2017; 103 (04) 609-614
  • 12 Monllau JC, Gelber PE, Abat F. , et al. Outcome after partial medial meniscus substitution with the collagen meniscal implant at a minimum of 10 years' follow-up. Arthroscopy 2011; 27 (07) 933-943
  • 13 Schüttler KF, Pöttgen S, Getgood A. , et al. Improvement in outcomes after implantation of a novel polyurethane meniscal scaffold for the treatment of medial meniscus deficiency. Knee Surg Sports Traumatol Arthrosc 2015; 23 (07) 1929-1935
  • 14 Murphy EP, McGoldrick NP, Curtin M, Kearns SR. A prospective evaluation of bone marrow aspirate concentrate and microfracture in the treatment of osteochondral lesions of the talus. Foot Ankle Surg 2019; 25 (04) 441-448
  • 15 Chan JJ, Guzman JZ, Vargas L, Myerson CL, Chan J, Vulcano E. Safety and effectiveness of talus subchondroplasty and bone marrow aspirate concentrate for the treatment of osteochondral defects of the talus. Orthopedics 2018; 41 (05) e734-e737
  • 16 Rodriguez-Fontan F, Piuzzi NS, Kraeutler MJ, Pascual-Garrido C. Early clinical outcomes of intra-articular injections of bone marrow aspirate concentrate for the treatment of early osteoarthritis of the hip and knee: a cohort study. PM R 2018; 10 (12) 1353-1359
  • 17 McDougall RA, Canapp SO, Canapp DA. Ultrasonographic findings in 41 dogs treated with bone marrow aspirate concentrate and platelet-rich plasma for a supraspinatus tendinopathy: a retrospective study. Front Vet Sci 2018; 5: 98
  • 18 Henderson RG, Colberg RE. Pure bone marrow aspirate injection for chronic greater trochanteric pain syndrome: a case report. Pain Manag 2018; 8 (04) 271-275
  • 19 Gobbi A, Scotti C, Karnatzikos G, Mudhigere A, Castro M, Peretti GM. One-step surgery with multipotent stem cells and hyaluronan-based scaffold for the treatment of full-thickness chondral defects of the knee in patients older than 45 years. Knee Surg Sports Traumatol Arthrosc 2017; 25 (08) 2494-2501
  • 20 Hefti F, Müller W, Jakob RP, Stäubli HU. Evaluation of knee ligament injuries with the IKDC form. Knee Surg Sports Traumatol Arthrosc 1993; 1 (3-4): 226-234
  • 21 Ahlbäck S, Rydberg J. [X-ray classification and examination technics in gonarthrosis]. Lakartidningen 1980; 77 (22) 2091-2093 , 2096
  • 22 Faivre B, Bouyarmane H, Lonjon G, Boisrenoult P, Pujol N, Beaufils P. Actifit® scaffold implantation: influence of preoperative meniscal extrusion on morphological and clinical outcomes. Orthop Traumatol Surg Res 2015; 101 (06) 703-708
  • 23 Potter HG, Linklater JM, Allen AA, Hannafin JA, Haas SB. Magnetic resonance imaging of articular cartilage in the knee. An evaluation with use of fast-spin-echo imaging. J Bone Joint Surg Am 1998; 80 (09) 1276-1284
  • 24 Genovese E, Angeretti MG, Ronga M. , et al. Follow-up of collagen meniscus implants by MRI. Radiol Med (Torino) 2007; 112 (07) 1036-1048
  • 25 Kaminski R, Kulinski K, Kozar-Kaminska K. , et al. A prospective, randomized, double-blind, parallel-group, placebo-controlled study evaluating meniscal healing, clinical outcomes, and safety in patients undergoing meniscal repair of unstable, complete vertical meniscal tears (bucket handle) augmented with platelet-rich plasma. BioMed Res Int 2018; 2018: 9315815
  • 26 Ghazi Zadeh L, Chevrier A, Farr J, Rodeo SA, Buschmann MD. Augmentation techniques for meniscus repair. J Knee Surg 2018; 31 (01) 99-116
  • 27 Salamanna F, Contartese D, Nicoli Aldini N. , et al. Bone marrow aspirate clot: a technical complication or a smart approach for musculoskeletal tissue regeneration?. J Cell Physiol 2018; 233 (04) 2723-2732
  • 28 Gianakos AL, Sun L, Patel JN, Adams DM, Liporace FA. Clinical application of concentrated bone marrow aspirate in orthopaedics: a systematic review. World J Orthop 2017; 8 (06) 491-506
  • 29 Filardo G, Andriolo L, Kon E, de Caro F, Marcacci M. Meniscal scaffolds: results and indications. A systematic literature review. Int Orthop 2015; 39 (01) 35-46
  • 30 Ajiboye RM, Eckardt MA, Hamamoto JT, Sharma A, Khan AZ, Wang JC. Does age influence the efficacy of demineralized bone matrix enriched with concentrated bone marrow aspirate in lumbar fusions?. Clin Spine Surg 2018; 31 (01) E30-E35
  • 31 Ranmuthu CDS, Ranmuthu CKI, Russell JC, Singhania D, Khan WS. Are the biological and biomechanical properties of meniscal scaffolds reflected in clinical practice? A systematic review of the literature. Int J Mol Sci 2019; 20 (03) E632
  • 32 Duygulu F, Demirel M, Atalan G. , et al. Effects of intra-articular administration of autologous bone marrow aspirate on healing of full-thickness meniscal tear: an experimental study on sheep. Acta Orthop Traumatol Turc 2012; 46 (01) 61-67
  • 33 James EW, LaPrade CM, Feagin JA, LaPrade RF. Repair of a complete radial tear in the midbody of the medial meniscus using a novel crisscross suture transtibial tunnel surgical technique: a case report. Knee Surg Sports Traumatol Arthrosc 2015; 23 (09) 2750-2755
  • 34 Pierce TP, Wagner C, McInerney VK, Festa A, Scillia AJ. Lateral capsular meniscal tear in a cross-country runner. Orthopedics 2016; 39 (06) e1201-e1204
  • 35 Moran CJ, Atmaca S, Declercq HA, Cornelissen MJ, Verdonk PC. Cell distribution and regenerative activity following meniscus replacement. Int Orthop 2014; 38 (09) 1937-1944
  • 36 De Coninck T, Huysse W, Willemot L, Verdonk R, Verstraete K, Verdonk P. Two-year follow-up study on clinical and radiological outcomes of polyurethane meniscal scaffolds. Am J Sports Med 2013; 41 (01) 64-72
  • 37 Bulgheroni P, Murena L, Ratti C, Bulgheroni E, Ronga M, Cherubino P. Follow-up of collagen meniscus implant patients: clinical, radiological, and magnetic resonance imaging results at 5 years. Knee 2010; 17 (03) 224-229
  • 38 Schüttler KF, Haberhauer F, Gesslein M. , et al. Midterm follow-up after implantation of a polyurethane meniscal scaffold for segmental medial meniscus loss: maintenance of good clinical and MRI outcome. Knee Surg Sports Traumatol Arthrosc 2016; 24 (05) 1478-1484
  • 39 Monllau JC, Poggioli F, Erquicia J. , et al. Magnetic resonance imaging and functional outcomes after a polyurethane meniscal scaffold implantation: minimum 5-year follow-up. Arthroscopy 2018; 34 (05) 1621-1627
  • 40 Yanagisawa S, Kobayashi T, Ohsawa T. , et al. Sonographic evaluation of the medial aspect of the knee in a population-based cohort study. J Clin Ultrasound 2015; 43 (05) 318-321
  • 41 Kolaczek S, Hewison C, Caterine S. , et al. 3D strain in native medial meniscus is comparable to medial meniscus allograft transplant. Knee Surg Sports Traumatol Arthrosc 2019; 27 (02) 349-353
  • 42 Baynat C, Andro C, Vincent JP. , et al. Actifit synthetic meniscal substitute: experience with 18 patients in Brest, France. Orthop Traumatol Surg Res 2014; 100 (8, Suppl): S385-S389